Previous 10 | Next 10 |
home / stock / cgnsf / cgnsf news
Latest Peer-Reviewed Study Published in Frontiers in Public Health Highlights Cost-Efficiency and Improved Clinical Outcomes from Using Cognetivity's Proprietary CognICA(TM) Technology, Showing Savings of Over £40 Million Per Year Compared with Traditional Cognitive Assessment Tools in Prima...
Collaboration With Highly Rated Healthcare Provider Opens US Healthcare Market for Brain Health for AI Powered CognICA, Enabling Patient Access to Latest Alzheimer's Drugs Vancouver, British Columbia--(Newsfile Corp. - October 11, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTC Pink...
Program Designed to Identify Age-Related Brain Health Issues at an Early Stage, Allowing Effective Provision of Coordinated Care Vancouver, British Columbia--(Newsfile Corp. - October 3, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTC Pink: CGNSF) (FSE: 1UB) ("the Company" or "...
New Approach to Measuring Impact of Counselling to Deliver Next Generation Care to Mental Health Sufferers in North America Vancouver, British Columbia--(Newsfile Corp. - September 21, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "C...
CognICA Chosen as Winner of Best AI Product in Healthcare Award at CogX Festival Vancouver, British Columbia--(Newsfile Corp. - September 13, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") , a leading artificial intelligence (AI) hea...
CognICA Shortlisted for Most Innovative AI Product in Healthcare Award at CogX Festival Vancouver, British Columbia--(Newsfile Corp. - September 5, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") , a leading artificial i...
Cognetivity's Landmark ADePT Study, Funded by the UK Innovation Agency and Published in Leading Neuroscience Journal Demonstrates Unprecedented Sensitivity in Detecting Cognitive Impairment in Early Stage Alzheimer's Disease, Essential for Treatment With New Drugs Vancouver, British Columbia--(N...
Approval opens up a new major market for CognICA, providing a solution to the urgent requirement for large-scale early detection and monitoring for the rollout of incoming Alzheimer's disease drugs Vancouver, British Columbia--(Newsfile Corp. - August 2, 2023) - Cognetivity Neurosciences Ltd....
Vital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetivity Neurosciences' AI CognICA technology poised to play pivotal role in early detection and monitoring globally Vancouver, British Columbia--(Newsfile Corp. - July 7, 2023) - Cognetivity Neuroscienc...
Partnership will accelerate adoption of Cognetivity's AI platform in Japan and other Asia-Pacific territories Vancouver, British Columbia--(Newsfile Corp. - June 13, 2023) - Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) ("the Company" or "Cognetivity") , is t...
News, Short Squeeze, Breakout and More Instantly...
Cognetivity Neurosciences Ltd Company Name:
CGNSF Stock Symbol:
OTCMKTS Market:
Atlas Lithium Corporation (ATLX) is expected to report $-0.47 for Q4 2023 Capital Product Partners L.P. (CPLP) is expected to report $0.7 for Q4 2023 WisdomTree Inc. (WT) is expected to report $0.11 for Q4 2023 Mitsubishi Corporation (MSBHF) is expected to report for Q3 2024 C3is ...
POSCO Holdings Inc. American Depositary Shares (Each representing 1/4th of a share of) (PKX) is expected to report for Q4 2023 Middlefield Banc Corp. (MBCN) is expected to report $0.53 for Q4 2023 American Business Bank (AMBZ) is expected to report for Q4 2023 Regencell Bioscience Hol...
Comerica Incorporated (CMA) is expected to report $1.38 for Q4 2023 ICICI Bank Limited (IBN) is expected to report $0.32 for Q3 2024 Engie Brasil Energia S.A. ADR (EGIEY) is expected to report for Q4 2023 Auto Parts 4Less Group (FLES) is expected to report for quarter end 2023-10-31 ...